Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SGHT stock hub

Sight Sciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SGHTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
292.7M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
SGHT
In the news

Latest news · SGHT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-56.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-16.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SGHT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
214
Groups with data
11
Currency
USD
Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001531177
Company name
Sight Sciences, Inc.
Country
United States
Country code
US
Cusip
82657M105
Employees
186
Employees Change
-30%
Employees Change Percent
-13.89
Enterprise value
$249.5M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2021-07-15
Isin
US82657M1053
Last refreshed
2026-05-10
Market cap
$292.7M
Market cap category
Micro-Cap
Price
$5.38
Price currency
USD
Rev Per Employee
427,704.3x
Sector
Healthcare
Sic
3841
Symbol
SGHT
Website
https://www.sightsciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-12.73%
EV Sales Forward
2.89x
EV/Sales
3.14x
FCF yield
-8.68%
P/B ratio
5.39x
P/S ratio
3.68x
PS Forward
3.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-34.51%
EBITDA Margin
-33.95%
Gross margin
86.17%
Gross Profit
$68.6M
Gross Profit Growth
2.46%
Gross Profit Growth Q
12.48%
Gross Profit Growth3 Y
2.91%
Gross Profit Growth5 Y
27.43%
Net Income
$-37.3M
Net Income Growth Quarters
5%
Net Income Growth Years
3%
Pretax Margin
-46.85%
Profit Margin
-46.83%
Profit Per Employee
$-200,280
ROA
-14.34
Roa5y
-19.08
ROCE
-29.99
ROE
-56.64
Roe5y
-46.38
ROIC
-16.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
88.19%
Cagr3y
-18.66%
EPS Growth Quarters
5
EPS Growth Years
5
Revenue Growth
1.85x
Revenue Growth Q
12.51x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
1.86x
Revenue Growth5 Y
21.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.66
Assets
$109.7M
Cash
$85M
Current Assets
$106.5M
Current Liabilities
$18.2M
Debt
$41.8M
Debt Equity
$0.77
Equity
$53.9M
Interest Coverage
-5.33
Liabilities
$55.8M
Long Term Assets
$3.2M
Long Term Liabilities
$37.6M
Net Cash
$43.2M
Net Cash By Market Cap
$14.76
Net Cash Growth
-36.75%
Net Debt Equity
$-0.8
Tangible Book Value
$53.9M
Tangible Book Value Per Share
$1
WACC
16.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.86
Inventory Turnover
1.72
Net Working Capital
$7.5M
Quick ratio
5.26
Working Capital
$88.3M
Working Capital Turnover
$0.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-4.4%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
88.11%
200-day SMA
5.14
3Y total return
-46.2%
50-day SMA
4.07
50-day SMA vs 200-day SMA
50under200
All Time High
42.57
All Time High Change
-87.36%
All Time High Date
2021-08-02
All Time Low
1.04
All Time Low Change
417.31%
All Time Low Date
2023-10-27
ATR
0.35
Beta
2.37
Beta1y
2.92
Beta2y
1.59
Ch YTD
-32.16
High
5.66
High52
9.24
High52 Date
2025-12-26
High52ch
-41.75%
Low
5.16
Low52
2.81
Low52 Date
2025-05-08
Low52ch
91.46%
Ma50ch
32.06%
Premarket Change Percent
4.92
Premarket Price
$5.55
Premarket Volume
5,762
Price vs 200-day SMA
4.63%
RSI
71.21
RSI Monthly
47.37
RSI Weekly
53.12
Sharpe ratio
1.11x
Sortino ratio
1.96
Total Return
-4.4%
Tr YTD
-32.16
Tr1m
53.71%
Tr1w
20.9%
Tr3m
-8.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

13
MetricValue
Analyst Count
7
Analyst Count Top
1
Analyst Price Target Top
$6.5
Analyst Ratings
Buy
Analyst Ratings Top
Hold
Earnings EPS Estimate
$-0.2
Earnings Revenue Estimate
18,552,584x
Earnings Revenue Estimate Growth
105,954,120.45x
Operating Income
$-27.5M
Operating margin
-34.51
Price target
$9.08
Price Target Change
$68.77
Price Target Change Top
$20.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
35,689,191%
Float Percent
65.59%
Shares Insiders
19.01%
Shares Institutions
33.08%
Shares Out
54,409,942
Shares Qo Q
1.62%
Shares Yo Y
4.4%
Short Float
3.01%
Short Ratio
4.04
Short Shares
1.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-37.1M
Average Volume
348,356.7x
Bv Per Share
1
CAPEX
$-284,000
Ch1m
53.71
Ch1w
20.9
Ch1y
88.11
Ch3m
-8.35
Ch3y
-46.2
Ch6m
-7.56
Change
1.7%
Change From Open
-0.19
Close
5.29
Days Gap
1.89
Depreciation Amortization
441,000
Dollar Volume
1,915,323
Earnings Date
2026-05-06
Earnings Time
amc
EBIT
$-27.5M
EBITDA
$-27M
EPS
$-0.71
F Score
4
FCF
$-25.4M
FCF EV Yield
-10.18x
FCF Per Share
$-0.47
Financing CF
1,863,000
Fiscal Year End
December
Founded
2,011
Income Tax
$-20,000
Investing CF
-284,000
Ipr
-77.58
Iprfo
-82.07
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-03-04
Ma150
5.61
Ma150ch
-4.12%
Ma20
4.28
Ma20ch
25.7%
Net CF
-23,539,000
Next Earnings Date
2026-08-06
Open
5.39
Optionable
Yes
Position In Range
44
Post Close
5.38
Postmarket Change Percent
1.86
Postmarket Price
$5.48
Ppne
2,820,000
Pre Close
5.29
Price Date
2026-05-08
Ptbv Ratio
5.43
Relative Volume
1.02x
Revenue
79,553,000x
SBC By Revenue
14.66x
Share Based Comp
11,664,000
Tax By Revenue
-0.03x
Tr6m
-7.56%
Us State
California
Volume
356,008
Z Score
-1.55
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SGHT pay a dividend?

Capital-return profile for this ticker.

Performance

SGHT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+88.1%
S&P 500 1Y: n/a
3Y total return
-46.2%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SGHT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+33.1%
Float: +65.6% of shares outstanding
Insider ownership
+19.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+3.0%
4.0 days to cover
Y/Y dilution
+4.4%
Negative means the company is buying back shares.
Technical

SGHT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
71.2
Above 70: short-term overbought
Price vs 200-day MA
+4.6%
50/200-day relationship not available
Beta (5Y)
2.37
More volatile than the market
Sharpe ratio
1.11
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SGHT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SGHT stock rating?

Sight Sciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SGHT analysis?

The full report lives at /stocks/SGHT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SGHT?

The latest report frames SGHT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SGHT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.